Let's talk medical research

Parkinson’s disease is a progressive nervous system condition that impacts movement. Due to the diversity of the disease, the nature and severity of symptoms are often a bit different from person to person, and not all people who have Parkinson’s will experience every symptom. Parkinson’s patients experience progression at different speeds.

Millions of Americans are affected by mental illness every day, either directly or indirectly. Each year, our partners at the National Alliance on Mental Illness (NAMI) and people across the country raise awareness of mental illness, fight discrimination, and provide support through Mental Illness Awareness Week (MIAW). October 10th, the last day of MIAW, is World Mental Health Day.

Knee osteoarthritis is the most common form of arthritis worldwide, and its prevalence is expected to continue to rise for years to come. For those that live with this condition, it causes pain, tiredness, loss of flexibility, a grating sensation, bone spurs, and swelling — all constant reminders of the need for new and better treatment options to replace the cartilage that has worn down over ...

We’re excited to share the premiere of Talk of the Towne, our new podcast that focuses on the ultimate sweet spot: that special place where science and patients converge.

Parkinson's disease is a disorder that can involve several different kinds of uncontrolled movements. Some are caused by the disease, such as tremor and gait freezing, while dyskinesia – uncontrolled jerking or twisting movement – is caused by long-term levodopa use. We unpack how dyskinesia affects movement in Parkinson’s disease and how it’s usually treated.

Clinical trials for lupus are investigating potential treatments and need volunteers to take part. The research process can be confusing, though. If you're interested in finding a lupus clinical trial but don't know where to start, we've collected a list of some of the most common questions patients ask about research participation.

When the pandemic began, more than 1,000 trials were delayed as the focus shifted to minimizing coronavirus exposure and driving COVID-19 vaccine and treatment trials. The reasons were varied — patients weren’t allowed into studies, study starts were delayed, and recruitment was slow. One thing is clear: the impact of these delays on the progress of medical research will likely be felt for years ...

Myasthenia gravis (MG) is a rare condition that affects approximately 36,000 to 60,000 individuals in the United States. Even though there are a variety of treatment options, it can be difficult to predict symptom flare-ups. Creative approaches are necessary to provide the best outcomes for patients.

Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, is a chronic autoimmune disease. Researchers estimate that about 65 out of every 100,000 women in the United States have PBC; this number is much lower in men. When a person has PBC, the immune system attacks the small bile ducts, which can cause damage to the liver.

In the United States, there are an estimated 25-30 million individuals living with a rare disease, which is defined as a condition that affects fewer than 200,000 people in the US.